Anti-Inflammatory Therapeutics Market: Impact of Aging Population
The Anti-Inflammatory Therapeutics Market is significantly influenced by the global aging population. The United Nations estimates that the global population aged 65 and over is expected to increase from approximately 703 million in 2019 to over 1.5 billion by 2050. This demographic shift leads to a rise in age-related inflammatory conditions, prompting healthcare providers to seek effective anti-inflammatory treatments.
The increasing prevalence of conditions such as osteoarthritis, rheumatoid arthritis, and inflammatory bowel disease among the elderly population is driving the demand for anti-inflammatory therapeutics. Pharmaceutical companies are focusing on developing age-specific formulations to address the unique needs of geriatric patients.